In addition, a decreased neuroinflammatory state was observed in a Ctsz knockout mouse with experimental autoimmune encephalomyelitis (Allan et al., 2017), further supporting the involvement of Ctsz in augmenting microglial pro-inflammatory activities, and thereby potentially being a therapeutic target in AD. The gene discussed is CTSZ; the disease is experimental autoimmune encephalomyelitis.